Velocity BioGroup is a strategic group of long-time business executives in the pharmaceutical, biologics, medical devices, and Federal Markets, with very high-level relationships in the commercial and government payer world, public relations and advocacy communities.The primary function of the Velocity BioGroup team is to support your organization in framing a compelling formula for the success of your key products introduced in the market.
CHIEF EXECUTIVE OFFICER
Pat's experience and expertise as a senior pharma executive include government and public relations, sales management, health systems strategy, contract negotiations & pricing. She has for six years served as an Executive Advisor for Health Care Sustainability to the Vietnam Veterans of America.
Pat has twenty-year+ specialization in strategy, state & federal policies, business, and health systems management. This includes:
Sales & sales management expertise in the pharmaceutical industry with three leading companies (Abbott Laboratories, Schering-Plough, GlaxoSmithKline)
Direct and management level customer development
Successful nine-figure contract negotiations for public healthcare system product access
Management of internal and external strategy teams - including managers, directors, area vice presidents, consultants, lobbyists and advocacy managers
CHIEF OPERATIONS OFFICER
Michael's career includes manufacturing, production and research engineering in the Defense Industry, with an MBA (Washington Univ. St. Louis Olin School of Business), specializing in international business development and business operations/process improvement. Michael has a Master Black Belt in Six Sigma (Measure, Root Cause, Adjust, Optimize, Feedback), certifications and complex applications in ISO, Kaizen and Lean Technologies, Statistical Process Control, Taguchi (known also as Design of Experiments) and the Goldratt Institute’s Theories of Constraint. Michael leads Velocity BioGroup's IT and Data Security efforts for internal and external client purposes as well as lending perspective from his research experience in the Department of Defense.
DIRECTOR OF FINANCE
Maureen Sacho has over 25 years of Human Resources & Accounting experience. Prior to joining Velocity BioGroup, she has worked in a number of industries including Printing, Manufacturing, Construction, and Association Management overseeing several non-profit organizations. Most of her career she has worked directly with Board of Directors, CEOs, Presidents, and Controllers.
Maureen has developed an expertise in the role of a Liaison with Attorneys, outside CPA Firms, Clients, and Vendors. She is proficient in numerous software programs and has extensive experience in office administration, payroll services, accounting and tax services. Her professionalism and attention to detail, as well as her commitment to client and team member’s needs, is what truly sets her apart.
DIRECTOR, POLICY & MARKET STRATEGY
Karen joined Velocity Biogroup in 2018 with 25 years of biopharmaceutical experience gained in multiple specialties and roles. In each role she has quickly exceeded expectations leading to positions of greater responsibility, awards, and accolades. Karen has spent the bulk of her pharmaceutical career focused in the CNS arena with the last 15 years specifically in the addiction medicine arena. She has had direct responsibilities in market development, market access, government affairs, direct sales and sales management.
Karen's strength lies in her ability to rapidly visualize the macro picture of possible market and sales strategies and the mixture of components needed for success. She then quickly assesses the most beneficial, realistic and cost-effective approaches and helps clients work through potential obstacles. As Director of Strategic Alliances Karen works closely with clients to foster beneficial relationships with key partners including professional organizations, state and federal agencies.
DIRECTOR OF ANALYTICS
Jeff has performed as Market Access Manager for Medicaid projects, Head of Analytics covering all markets, and Director of Analytics and Forecasting in his four years with Velocity Biogroup.
Leveraging skills in several data analysis platforms, Jeff can organize and create insightful tools informed by a variety of data sources.
Jeff has managed all coding and calculating for 25+ forecasts/simulations covering both the federal and commercial spaces. He can design tools that manage hundreds of thousands of fully customized predictions, allowing for efficient decision making and optimized revenue.
FEDERAL ACCOUNT DIRECTOR
top revenue producer and trainer in the Federal space with established relationships in DODs, VAs across Texas, Louisiana, Oklahoma, Arkansas, Mississippi, including San Antonio Military Medical Center, Darnall Army Hospital, Fort Hood, William Beaumont, El Paso, Kessler AFB, MS.
Career experience in contracting, formulary, P&T, buy & bill, reimbursements.Veteran experience in C-suites partnering with IDNs and Hospital Systems throughout Texas and Louisiana including UTMD Anderson Cancer Center, Baylor College of Medicine, Memorial Hermann, CHI St. Luke’s, Ochsner Health System
Proven history of generating 7-figure revenues in specialized markets and academic research centers. Experienced in Neurology, Pulmonology/Critical Care, Anesthesiology, Oncology, Medical Devices, Injectables, Cardiology, Infectious Diseases, Surgery, GI, contracting, formulary processes, reimbursements, MCOs, ACOs, GPOs, supply chains.
A natural leader and award-winning motivator for sales teams elevating regional and national performance. Consistently deliver outstanding sales results earning multiple National Awards including Presidents Club, 300 Club, Top 5% Sales Performer, National Trainer Excellence Award Winner.
VICE PRESIDENT, STRATEGY
Jill Duffy has held several strategic clinical leadership positions, most recently as the Director of Operations for the National Oncology Program at the Department of Veterans Affairs. Her primary focus over the past few years has been to provide strategic, programmatic, and clinical leadership in establishing the National Precision Oncology Program within the VA to deliver cutting edge technology and personalized oncology treatments to patients. Jill helped develop the National Tele-Oncology program for the VA system, building enterprise-wide tele-oncology infrastructure in an effort to decrease health disparities and support access to highly specialized care for rural Veterans across the nation.
Jill also led the development of oncology clinical data capture tools for the VA EHR system, in an effort to both standardize and monitor oncology care and patient outcomes across the VA. In partnership with National Pharmacy Benefits Informatics Group, she created informatics tools to query structured clinical data in VA EHR for national quality metrics assessments and oncology program reviews.
Jill has practiced outpatient and inpatient hematology/oncology in both private practice and at the VA as well as infectious diseases at Duke University Hospital. Jill holds a consulting faculty position at the Duke University School of Medicine where she has taught hematology and oncology courses for the last decade.
Jill graduated from Worcester Polytechnic Institute in Worcester, MA with a B.S. in Biology and Biotechnology, obtained her Master’s in Health Sciences, Physician Assistant degree at Duke University School of Medicine University and MBA from Fuqua School of Business at Duke University.
DIRECTOR OF MEDICAID SERVICES
Dan Keeney is a results-driven executive with extensive experience leading state government affairs teams in gaining product access and furthering company interests in the government arena. Dan works with client companies' managed markets and sales teams to achieve preferred product access on Medicaid formularies by channeling effective input into P&T committee meeting product reviews and decision-making processes within the increasingly challenging Medicaid space.
Dan has led a team of Medicaid account managers, lobbyists, ADAP specialists and advocacy managers in achieving successful policy outcomes across the Midwest sector. More recently, Dan led the Medicaid account management team for the Western 28 states for 26 medicines plus HIV and vaccine products for one of the world's largest pharmaceutical companies.
Among Dan’s skill sets are:
Developing strategies for formulary placement, advocating with Medicaid Pharmacy, P&T/DUR Committee members & KOLs
Managing regulatory and statutory requirements needed for product access
Tracking P&T / DUR committee meetings including clinical and bid submission due dates
Tracking and lobbying relevant legislation affecting products or the competitive landscape
Robert Mock has been in the Federal Market business for 25+ years. Robert is an expert in senior-level sales and training leadership within the pharmaceutical sales industry. Expertise includes Multi-State Territory Management, Key
Account Management, Federal Sales, Sales Management, and Training, New Business
Development, New Product Launches, Strategic Sales Forecasting and Planning, Market Visits, and Field Strategies.
Emphasis on: Pharmaceutical Sales, Multi-State Management, Award-winning Federal Regional Sales Director with extensive experience overseeing the sales and operations of a 16-state region with annual sales revenue of more than $105 Million. Well-developed skills hiring, training, supervising, and motivating sales
teams to perform at their best. Robert is a dedicated leader with excellent communication skills and a proven track record of success increasing sales revenue, leading sales and training programs, and developing sales staff into award-winning Sales Managers. Among all this Robert Mock has won the "Baltic Sea Diamond Award" which is only given to the top 2% in the entire company at GSK.
Among Pharmaceutical Sales Robert skill set are:
Sales Training and Mentoring
Developing and Implementing field strategies
MANAGER, INSIDE FEDERAL SALES
Rachael Mercer attended Northeastern University to study Biochemistry. She earned experience through co-oping in the pharmaceutical and biotechnology industry as a research and development intern for Biogen and Takeda Pharmaceuticals. She also completed medical research through the co-op program at Brigham and Women's Hospital. She has worked the last several years conducting primary and secondary research for our pharmaceutical, biotechnology, and medical diagnostic clients focusing on US Government markets, and has had direct responsibilities to grow client sales in both the federal market and TRICARE community through our virtual platform. She has aided client companies to gain federal access for their products and personnel as well. Her experience is in a multitude of different therapeutic areas to help build national sales strategies - most recently supporting the entire industry through her regularly updated mapping tool which helps clients track the incidence of COVID-19 cases at VA Medical Centers across the nation.
•Singular expertise in OAK & product launches for chronic and acute pain
•Decades-long relationships with leading KOLs in OAK, ortho & pain
•Extensive experience negotiating collaborative, customized agreements based on outcomes & health economics - with large key accounts (private & academic practices, ASCs, and hospitals) – including Rothman, Northwell, HSS, Cleveland Clinic, Duke and others across the U.S.